Chronic condition therapeutic developer Sweetch announced today that Dr. Robert A. Gabbay has joined the company as an advisor.
Gabbay currently serves as the chief scientific and medical officer at the American Diabetes Association, leading the organization’s efforts to drive discovery in diabetes research, care and prevention. He also serves as an associate professor of medicine at Harvard Medical School, having previously been CMO at Joslin Diabetes Center.
Get the full story at our sister site, Drug Delivery Business News.